Want to see HK:1501 full AI Analyst Report?
Top Page
Shanghai Kindly Medical Instruments Co., Ltd. Class H
(1501)
Select Model
Select Model
Rating:61Neutral
Price Target:
HK$36.00
â–²(22.87% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by solid underlying operating performance and improved 2025 cash generation, but is held back by the sharp increase in leverage and a weakening technical backdrop (trading below major moving averages with soft momentum). Valuation is moderate with a low dividend yield, offering only limited offset.
Positive Factors
Revenue Growth
Steady revenue expansion, including 12.7% annual growth in 2025, indicates continued demand for the company’s medical devices and consumables. Sustained top-line growth can support operating scale, strengthen customer reach, and provide a durable base for future earnings.
Negative Factors
Higher Leverage
The sharp increase in debt materially reduces financial flexibility and makes the company more sensitive to earnings volatility. Higher leverage can require greater cash allocation to financing obligations, potentially limiting investment capacity and increasing balance-sheet risk over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Steady revenue expansion, including 12.7% annual growth in 2025, indicates continued demand for the company’s medical devices and consumables. Sustained top-line growth can support operating scale, strengthen customer reach, and provide a durable base for future earnings.
Read all positive factors
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$6.97B
Dividend Yield0.77%
Average Volume (3M)263.56K
Price to Earnings (P/E)24.3
Beta (1Y)0.02
Revenue Growth34.94%
EPS Growth12.99%
CountryHK
Employees2,180
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)1.18
Shares Outstanding211,200,000
10 Day Avg. Volume246,520
30 Day Avg. Volume263,560
Financial Highlights & Ratios
PEG Ratio1.13
Price to Book (P/B)2.32
Price to Sales (P/S)4.35
P/FCF Ratio16.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.39
Revenue Forecast (FY)HK$1.23B
Shanghai Kindly Medical Instruments Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Shanghai Kindly Medical Instruments Co., Ltd., founded in 2006 and based in Shanghai, China, focuses on the research, development, production, and international sales of cardiovascular interventional medical devices. The company's products reach c...
How the Company Makes Money
The company primarily makes money by selling medical devices and related disposable/consumable products to healthcare providers (e.g., hospitals and clinics), generating revenue on a per-unit basis through product shipment/recognized sales. Revenu...
Shanghai Kindly Medical Instruments Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
61
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.19B | 1.07B | 851.95M | 752.84M | 585.88M | 464.68M |
| Gross Profit | 725.48M | 636.79M | 537.66M | 438.07M | 332.49M | 275.75M |
| EBITDA | 378.17M | 353.06M | 255.43M | 225.88M | 159.99M | 168.81M |
| Net Income | 229.06M | 218.79M | 191.91M | 156.46M | 131.71M | 142.96M |
Balance Sheet | ||||||
| Total Assets | 3.87B | 3.13B | 2.26B | 2.03B | 1.83B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 1.32B | 630.81M | 554.51M | 434.40M | 528.27M | 640.55M |
| Total Debt | 716.25M | 716.26M | 243.69M | 94.78M | 48.83M | 13.40M |
| Total Liabilities | 1.03B | 1.04B | 473.39M | 351.25M | 273.23M | 183.63M |
| Stockholders Equity | 2.76B | 2.00B | 1.77B | 1.65B | 1.51B | 1.40B |
Cash Flow | ||||||
| Free Cash Flow | 212.14M | 278.17M | 59.80M | -53.05M | -62.75M | -205.07M |
| Operating Cash Flow | 223.60M | 340.98M | 225.54M | 178.15M | 180.46M | 72.76M |
| Investing Cash Flow | -212.45M | -491.99M | -187.31M | -283.81M | -316.18M | -268.08M |
| Financing Cash Flow | 141.20M | 263.40M | 56.97M | 8.06M | 9.72M | -31.07M |
Shanghai Kindly Medical Instruments Co., Ltd. Class H Technical Analysis
Negative
29.30
Price Trends
33.01
Negative
33.88
Negative
32.42
Positive
Market Momentum
0.33
Positive
44.89
Neutral
36.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1501, the sentiment is Negative. The current price of 29.3 is below the 20-day moving average (MA) of 33.97, below the 50-day MA of 33.01, and below the 200-day MA of 32.42, indicating a neutral trend. The MACD of 0.33 indicates Positive momentum. The RSI at 44.89 is Neutral, neither overbought nor oversold. The STOCH value of 36.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1501.
Shanghai Kindly Medical Instruments Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$7.22B | 10.49 | 20.11% | 3.79% | 12.50% | 44.44% | |
78 Outperform | HK$3.17B | 9.11 | 10.50% | 5.33% | 16.25% | 7.80% | |
69 Neutral | HK$16.27B | 69.70 | 5.84% | 10.97% | ― | ― | |
67 Neutral | HK$1.38B | 29.31 | 1.10% | 3.18% | -1.64% | -68.67% | |
61 Neutral | HK$6.97B | 24.33 | 9.64% | 0.77% | 34.94% | 12.99% | |
60 Neutral | HK$14.70B | 9.22 | 5.64% | 5.34% | 7.47% | -26.89% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
33.56
0.96
2.94%
HK:1066
Shandong Weigao Group Medical Polymer Co
3.24
-2.24
-40.88%
HK:1358
PW Medtech Group Ltd.
0.98
-0.47
-32.32%
HK:3600
Modern Dental Group Limited
7.65
2.38
45.18%
HK:6699
Angelalign Technology Inc.
96.15
29.84
44.99%
HK:6929
OrbusNeich Medical Group Holdings Limited
3.83
-0.45
-10.51%
Shanghai Kindly Medical Instruments Co., Ltd. Class H Corporate Events
Shanghai INT Medical Reshapes Board as It Prepares Mainland A-Share Listing
Aug 24, 2026
Shanghai INT Medical Instruments announced several board changes as it prepares for a mainland A-share listing, including the resignation of non-executive director Wang Ruiqin due to personal work adjustments. The company also disclosed that long-...
Shanghai INT Medical Instruments Sets Out Board and Committee Structure
Aug 24, 2026
Shanghai INT Medical Instruments Co., Ltd. has detailed the composition of its board of directors, which includes two executive directors, four non-executive directors, an employee representative director and three independent non-executive direct...
Shanghai INT Medical Instruments Boosts Revenue and Margins on Interventional Device Growth
Aug 24, 2026
Shanghai INT Medical Instruments reported robust growth for the six months ended 30 June 2026, with revenue rising 29.28% to RMB596.06 million, driven mainly by stronger sales of interventional medical devices. Revenue from these core products cli...
Shanghai Kindly Medical Sets Board Meeting to Approve Interim Results and Consider Dividend
Aug 12, 2026
Shanghai Kindly Medical Instruments Co., Ltd., a PRC-incorporated joint stock company listed in Hong Kong, operates in the medical instruments industry, supplying a range of healthcare-related devices through its subsidiaries. Its board comprises ...
Shanghai INT Medical Sets Extraordinary General Meeting and Closes Register of Members
Aug 10, 2026
Shanghai INT Medical Instruments Co., Ltd. has scheduled its first extraordinary general meeting of 2026 for 24 September, and will temporarily close its register of members from 25 August to 24 September to determine shareholder eligibility. Shar...
Shanghai INT Medical Expands Stake in Target Firm via US$55 Million Indirect Acquisition
Jul 23, 2026
Shanghai INT Medical Instruments has agreed, via a wholly owned subsidiary, to acquire 100% of the partnership interests in Shanghai Maoyi for US$55.1 million, which indirectly holds 579,866 series B preferred shares in a target company, equal to ...
Shanghai INT Medical Grants Performance-Linked H-Share Awards to Executive Director
Jun 29, 2026
Shanghai INT Medical Instruments has granted H-share awards under its existing H Share Award and Trust Scheme, which uses company funds for on-market purchases rather than issuing new shares. The awards, which form part of its long-term incentive ...
Shanghai INT Details Valuation and Compliance for Pulin Medical Stake Acquisition
Jun 25, 2026
Shanghai INT Medical Instruments Co., Ltd. has provided further details on its planned acquisition of a 35% equity stake in its non-wholly owned subsidiary, Shanghai Pulin Medical Instruments Co., Ltd., reinforcing its strategic focus on consolida...
Shanghai INT Medical Instruments Raises Stake in Target Company via Second Discloseable Acquisition
Jun 25, 2026
Shanghai INT Medical Instruments has agreed to further increase its stake in a target healthcare company by acquiring an additional 0.79% of its share capital, comprising 119,545 Series B preferred shares, for US$10 million. This follows its earli...
Shanghai INT Medical Instruments Starts Pre-Listing Tutoring for Potential A-Share Issue
Jun 12, 2026
Shanghai INT Medical Instruments Co., Ltd., a PRC-based medical device company listed in Hong Kong, plans to further expand its capital markets footprint by pursuing a potential A-share issuance on a stock exchange in mainland China. The move unde...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.